Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Consistent sleep onset and maintenance of body weight after weight loss: An analysis of data from the NoHoW trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Early occupational intervention for people with low back pain in physically demanding jobs: A randomized clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Antibiotic treatment during early childhood and risk of type 1 diabetes in children: A national birth cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Danish Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Prediction of carotid intima-media thickness and its relation to cardiovascular events in persons with type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Naeimeh Atabaki-Pasdar
  • Mattias Ohlsson
  • Ana Viñuela
  • Francesca Frau
  • Hugo Pomares-Millan
  • Mark Haid
  • Angus G Jones
  • E Louise Thomas
  • Robert W Koivula
  • Azra Kurbasic
  • Pascal M Mutie
  • Hugo Fitipaldi
  • Juan Fernandez
  • Adem Y Dawed
  • Giuseppe N Giordano
  • Ian M Forgie
  • Timothy J McDonald
  • Femke Rutters
  • Henna Cederberg
  • Elizaveta Chabanova
  • Matilda Dale
  • Federico De Masi
  • Cecilia Engel Thomas
  • Kristine H Allin
  • Tue H Hansen
  • Alison Heggie
  • Mun-Gwan Hong
  • Petra J M Elders
  • Gwen Kennedy
  • Tarja Kokkola
  • Helle Krogh Pedersen
  • Anubha Mahajan
  • Donna McEvoy
  • Francois Pattou
  • Violeta Raverdy
  • Ragna S Häussler
  • Sapna Sharma
  • Henrik S Thomsen
  • Jagadish Vangipurapu
  • Henrik Vestergaard
  • Leen M 't Hart
  • Jerzy Adamski
  • Petra B Musholt
  • Soren Brage
  • Søren Brunak
  • Emmanouil Dermitzakis
  • Gary Frost
  • Torben Hansen
  • Markku Laakso
  • Oluf Pedersen
  • Martin Ridderstråle
  • Hartmut Ruetten
  • Andrew T Hattersley
  • Mark Walker
  • Joline W J Beulens
  • Andrea Mari
  • Jochen M Schwenk
  • Ramneek Gupta
  • Mark I McCarthy
  • Ewan R Pearson
  • Jimmy D Bell
  • Imre Pavo
  • Paul W Franks
Vis graf over relationer

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes serious health complications in individuals with and without type 2 diabetes (T2D). Early diagnosis of NAFLD is important, as this can help prevent irreversible damage to the liver and, ultimately, hepatocellular carcinomas. We sought to expand etiological understanding and develop a diagnostic tool for NAFLD using machine learning.

METHODS AND FINDINGS: We utilized the baseline data from IMI DIRECT, a multicenter prospective cohort study of 3,029 European-ancestry adults recently diagnosed with T2D (n = 795) or at high risk of developing the disease (n = 2,234). Multi-omics (genetic, transcriptomic, proteomic, and metabolomic) and clinical (liver enzymes and other serological biomarkers, anthropometry, measures of beta-cell function, insulin sensitivity, and lifestyle) data comprised the key input variables. The models were trained on MRI-image-derived liver fat content (<5% or ≥5%) available for 1,514 participants. We applied LASSO (least absolute shrinkage and selection operator) to select features from the different layers of omics data and random forest analysis to develop the models. The prediction models included clinical and omics variables separately or in combination. A model including all omics and clinical variables yielded a cross-validated receiver operating characteristic area under the curve (ROCAUC) of 0.84 (95% CI 0.82, 0.86; p < 0.001), which compared with a ROCAUC of 0.82 (95% CI 0.81, 0.83; p < 0.001) for a model including 9 clinically accessible variables. The IMI DIRECT prediction models outperformed existing noninvasive NAFLD prediction tools. One limitation is that these analyses were performed in adults of European ancestry residing in northern Europe, and it is unknown how well these findings will translate to people of other ancestries and exposed to environmental risk factors that differ from those of the present cohort. Another key limitation of this study is that the prediction was done on a binary outcome of liver fat quantity (<5% or ≥5%) rather than a continuous one.

CONCLUSIONS: In this study, we developed several models with different combinations of clinical and omics data and identified biological features that appear to be associated with liver fat accumulation. In general, the clinical variables showed better prediction ability than the complex omics variables. However, the combination of omics and clinical variables yielded the highest accuracy. We have incorporated the developed clinical models into a web interface (see: https://www.predictliverfat.org/) and made it available to the community.

TRIAL REGISTRATION: ClinicalTrials.gov NCT03814915.

OriginalsprogEngelsk
TidsskriftPLOS Medicine
Vol/bind17
Udgave nummer6
Sider (fra-til)e1003149
ISSN1549-1277
DOI
StatusUdgivet - jun. 2020

ID: 60273751